RNF168 p.Ile79Val
c.235A>G · rs144821850 · VCV2057288
Computational evidence
| Protein change | ||
| AlphaMissense | 0.065 | likely benign |
|---|---|---|
| REVEL | 0.01 | strongly benign-leaning |
| SaProt | LLR -6.61 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | Δ0.59 | donor gain · deltas |
| Pangolin | Δ0.25 | gain · loss 0.00 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP -0.12 | GERP -3.7 |
| Regional constraint | o/e 1.06 | unconstrained · MANE · 31 kb · p 0.1 · regional, not allelic |
| Overall | ||
| CADD | 7.427 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 0.548% | 182 |
| European (non-Finnish)grpmax | 0.0431% | 2,323 |
| Remaining individualsnot grpmax-eligible | 0.0256% | 3,905 |
| Middle Eastern | 0.0164% | 6,084 |
| Admixed American | 0.015% | 6,666 |
| Finnishnot grpmax-eligible | 0.00781% | 12,808 |
| African / African-American | 0.004% | 24,980 |
| South Asian | 0.0022% | 45,541 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- RNF168
- Protein
- p.Ile79Val
- Coding
- c.235A>G
- MANE Select
- NM_152617
- dbSNP
- rs144821850
- Type
- single nucleotide variant
- Location
- chr3:196502939 (GRCh38)
- Gene constraint
- LOEUF 1.406 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 61.97 · 39 PDB
- Residue 79
- an α-helix
Similar variants
- RNF168 p.Ile79Met Uncertain significance ★★ ⚠ same residue
- RNF168 p.Arg131Ter Pathogenic/Likely pathogenic ★★ same type
- RNF168 p.Arg165Ter Pathogenic/Likely pathogenic ★★ same type
- RNF168 p.Glu138Ter Pathogenic/Likely pathogenic ★★ same type
- RNF168 p.Ala141Val Uncertain significance ★★ ⚠ same type
- RNF168 p.Ala7Ser Uncertain significance ★★ ⚠ same type
- RNF168 p.Arg131Gln Uncertain significance ★★ ⚠ same type
- RNF168 p.Arg132Trp Uncertain significance ★★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/rnf168-p-ile79val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown